GlassScriptPhysician profile
Julie A Bernell
NPI 1184627341
$1,631.02
in general payments reported to CMS, 2019-2025
28 companies · $70.27 in 2025
The $70.27 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $208 · 2021: $403 · 2022: $339 · 2023: $341 · 2024: $51.48 · 2025: $70.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.15 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $333.74 | 2019-2023 | Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $241.39 | 2021-2025 | |
| Avion Pharmaceuticals | $224.12 | 2019-2023 | Balcoltra |
| Astellas Pharma US INC | $130.11 | 2022-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $94.50 | 2019-2022 | |
| Myovant Sciences INC. | $69.64 | 2022 | |
| Millicent US INC | $66.57 | 2019-2024 | Femring, Intrarosa |
| Evofem Biosciences, INC. | $45.20 | 2020-2021 | |
| Optumhealth Care Solutions, LLC | $40.22 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Ethicon US, LLC | $35.01 | 2022 | |
| Therapeuticsmd, INC. | $33.30 | 2019-2021 | |
| Exeltis, USA INC. | $32.90 | 2021 | |
| Roche Diagnostics Corporation | $29.80 | 2019 | |
| Allergan, INC. | $27.48 | 2019 | |
| Sumitomo Pharma America, INC. | $27.08 | 2023 | Myfembree |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $23.77 | 2025 | Zurzuvae |
| Acessa Health INC. | $20.47 | 2020 | |
| Smith+Nephew, INC. | $19.44 | 2021 | |
| Scynexis, INC. | $18.19 | 2022 | |
| Duchesnay USA Incorporated | $14.64 | 2019 | |
| Meditrina | $13.99 | 2022 | |
| Shield Therapeutics INC | $13.91 | 2022 | |
| Kerecis Limited | $13.17 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Lupin INC. | $12.74 | 2019 | |
| Currax Pharmaceuticals LLC | $12.59 | 2020 | |
| Pfizer INC. | $12.52 | 2022 | |
| Minerva Surgical, INC | $12.36 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Bernell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.